<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="216220">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00270426</url>
  </required_header>
  <id_info>
    <org_study_id>SouthernMUC</org_study_id>
    <nct_id>NCT00270426</nct_id>
  </id_info>
  <brief_title>Benazepril for Advanced Chronic Renal Insufficiency</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Southern Medical University, China</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Southern Medical University, China</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to further determine whether benazepril, could safely slow the
      progression of renal dysfunction in non-diabetic patients with advanced renal insufficiency.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double-Blind</masking>
  </study_design_info>
  <condition>Chronic Kidney Failure</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Benazepril</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. serum creatinine concentration 1.5-5.0 mg/dL (133-442 µmol/L)

          2. creatinine clearance 20 to70 mL/min/1.73 m2, with variations of less than 30 percent
             in the three months before the screening evaluation

          3. non-diabetic renal disease

          4. persistent proteinuria (defined as urinary protein excretion greater than 0.3 g/day
             for three or more months without evidence of urinary-tract infection or overt heart
             failure [New York Heart Association class III–IV]).

        Exclusion Criteria:

          -  immediate need for dialysis; treatment with corticosteroids, non-steroidal
             anti-inflammatory drugs or immunosuppressive drugs; renovascular disease; myocardial
             infarction or cerebrovascular accident in the year preceding the trial;
             connective-tissue disease; obstructive uropathy.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Fan Fan Hou, M.D.,Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Southern Medical University</affiliation>
  </overall_official>
  <results_reference>
    <citation>Hou FF, Zhang X, Zhang GH, Xie D, Chen PY, Zhang WR, Jiang JP, Liang M, Wang GB, Liu ZR, Geng RW. Efficacy and safety of benazepril for advanced chronic renal insufficiency. N Engl J Med. 2006 Jan 12;354(2):131-40.</citation>
    <PMID>16407508</PMID>
  </results_reference>
  <verification_date>March 1999</verification_date>
  <lastchanged_date>May 4, 2006</lastchanged_date>
  <firstreceived_date>December 23, 2005</firstreceived_date>
  <keyword>Advanced Chronic Renal Insufficiency</keyword>
  <keyword>Benazepril</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Renal Insufficiency</mesh_term>
    <mesh_term>Renal Insufficiency, Chronic</mesh_term>
    <mesh_term>Kidney Failure, Chronic</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Benazepril</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
